Literature DB >> 26615186

New Standards for Negative Symptom Assessment.

William T Carpenter1, Jack J Blanchard2, Brian Kirkpatrick3.   

Abstract

Mesh：

Year:  2015        PMID： 26615186      PMCID： PMC4681567          DOI： 10.1093/schbul/sbv160

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  11 in total

1.  The brief negative symptom scale: psychometric properties.

Authors:  Brian Kirkpatrick; Gregory P Strauss; Linh Nguyen; Bernard A Fischer; David G Daniel; Angel Cienfuegos; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

2.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Authors:  Robert W Buchanan; Miriam Davis; Donald Goff; Michael F Green; Richard S E Keefe; Andrew C Leon; Keith H Nuechterlein; Thomas Laughren; Robert Levin; Ellen Stover; Wayne Fenton; Steve R Marder
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

4.  Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.

Authors:  Jack J Blanchard; Ann M Kring; William P Horan; Raquel Gur
Journal:  Schizophr Bull       Date:  2010-09-22       Impact factor: 9.306

5.  The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia.

Authors:  Silvana Galderisi; Alessandro Rossi; Paola Rocca; Alessandro Bertolino; Armida Mucci; Paola Bucci; Paola Rucci; Dino Gibertoni; Eugenio Aguglia; Mario Amore; Antonello Bellomo; Massimo Biondi; Roberto Brugnoli; Liliana Dell'Osso; Diana De Ronchi; Gabriella Di Emidio; Massimo Di Giannantonio; Andrea Fagiolini; Carlo Marchesi; Palmiero Monteleone; Lucio Oldani; Federica Pinna; Rita Roncone; Emilio Sacchetti; Paolo Santonastaso; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Mario Maj
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Authors:  William P Horan; Ann M Kring; Raquel E Gur; Steven P Reise; Jack J Blanchard
Journal:  Schizophr Res       Date:  2011-07-27       Impact factor: 4.939

7.  Factor structure of the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; L Elliot Hong; James M Gold; Robert W Buchanan; Robert P McMahon; William R Keller; Bernard A Fischer; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

8.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

Authors:  J S Strauss; W T Carpenter; J J Bartko
Journal:  Schizophr Bull       Date:  1974       Impact factor: 9.306

9.  The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Authors:  Ann M Kring; Raquel E Gur; Jack J Blanchard; William P Horan; Steven P Reise
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

10.  Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; William R Keller; Robert W Buchanan; James M Gold; Bernard A Fischer; Robert P McMahon; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2012-11-03       Impact factor: 4.939
View more
  9 in total

Review 1.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

2.  Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia.

Authors:  Dinesh K Shukla; Joshua John Chiappelli; Hemalatha Sampath; Peter Kochunov; Stephanie M Hare; Krista Wisner; Laura M Rowland; L Elliot Hong
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

3.  Negative Symptom Therapeutics.

Authors:  William T Carpenter; Robert W Buchanan
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; James M Gold
Journal:  Schizophr Bull       Date:  2016-05-12       Impact factor: 9.306

Review 5.  Transcranial Direct Current Stimulation of the Dorsolateral Prefrontal Cortex for Treatment of Neuropsychiatric Disorders.

Authors:  Qing Li; Yu Fu; Chang Liu; Zhiqiang Meng
Journal:  Front Behav Neurosci       Date:  2022-05-25       Impact factor: 3.617

6.  Correspondence between negative symptoms and potential sources of secondary negative symptoms over time.

Authors:  Aida Farreny; Mark Savill; Stefan Priebe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-02       Impact factor: 5.270

7.  Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS).

Authors:  Naoki Hashimoto; Atsuhito Toyomaki; Matsuhiko Oka; Keisuke Takanobu; Ryo Okubo; Hisashi Narita; Kan Kitagawa; Niki Udo; Tamaki Maeda; Shinya Watanabe; Yuka Oyanagi; Akane Miyazaki; Koki Ito; Ichiro Kusumi
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-23       Impact factor: 2.570

8.  Relationship of subjective quality of life with symptomatology, neurocognition and psychosocial functioning in first-episode psychosis: a structural equation modelling approach.

Authors:  Sandra Chi Yiu Wong; Wing Chung Chang; Christy Lai Ming Hui; Sherry Kit Wa Chan; Edwin Ho Ming Lee; Yi Nam Suen; Eric Yu Hai Chen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-25       Impact factor: 5.270

9.  Anhedonia Relates to the Altered Global and Local Grey Matter Network Properties in Schizophrenia.

Authors:  Byung-Hoon Kim; Hesun Erin Kim; Jung Suk Lee; Jae-Jin Kim
Journal:  J Clin Med       Date:  2021-03-31       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.